New Covenant Trust Company’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$295K Buy
3,248
+229
+8% +$20.9K 0.22% 75
2026
Q1
$310K Buy
3,019
+428
+17% +$48.3K 0.28% 64
2025
Q4
$322K Buy
2,591
+21
+0.8% +$2.67K 0.29% 55
2025
Q3
$344K Sell
2,570
-13
-0.5% -$1.71K 0.32% 50
2025
Q2
$347K Sell
2,583
-32
-1% -$4.22K 0.31% 47
2025
Q1
$342K Sell
2,615
-117
-4% -$14.9K 0.36% 48
2024
Q4
$308K Sell
2,732
-48
-2% -$5.55K 0.31% 51
2024
Q3
$313K Hold
2,780
0.3% 56
2024
Q2
$284K Sell
2,780
-50
-2% -$5.3K 0.33% 52
2024
Q1
$322K Buy
+2,830
New +$324K 0.32% 45

Other funds holding ABT

New Covenant Trust Company's ABT Position: Q2 2026 in Review

New Covenant Trust Company increased its Abbott (ABT) stake by 7.6% in Q2 2026, buying an estimated $20.9K and bringing the position to 3,248 shares worth $295K. The position accounts for 0.22% of the portfolio, ranked #75.

New Covenant Trust Company first reported a position in ABT in Q1 2024 and has held it in 10 quarters since. The position peaked at $347K in Q2 2025. 1,239 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • New Covenant Trust Company held 3,248 shares of Abbott worth $295K as of Q2 2026.
  • New Covenant Trust Company bought 229 Abbott shares in Q2 2026, an estimated $20.9K.
  • Abbott made up 0.22% of New Covenant Trust Company's portfolio in Q2 2026, its #75 holding.
  • New Covenant Trust Company first reported a position in Abbott in Q1 2024 and has held it in 10 quarters since.
  • New Covenant Trust Company's Abbott position peaked at $347K in Q2 2025.
  • 1,239 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on New Covenant Trust Company's 13F filing for Q2 2026, filed 14 Jul 2026.